Ally Financial Inc (ALLY) Stock Price Today
INVE Technologies partners with Trackonomy to integrate Physical AI into enterprise software.
INVE Technologies has formed a strategic partnership with Trackonomy to integrate Trackonomy's Physical AI platform into INVE's acquired enterprise software products. This collaboration aims to enhance software offerings with real-world operational d...
India's paints and coatings market to reach $21.17B by 2032, driven by construction and automotive growth.
The India paints and coatings market is projected to grow from $12.51 billion in 2026 to $21.17 billion by 2032, at a CAGR of 9.14%. Growth is fueled by expanding residential construction, rising demand for decorative repainting, and increased automo...
Toll Brothers opens luxury model homes at Hidden Vista, Palm Desert, starting from $1M
Toll Brothers has announced the grand opening of new luxury single-story model homes at Hidden Vista, a gated community in Palm Desert, California, on November 14. These homes offer up to 2,700 sq ft with 3-4 bedrooms, modern open floor plans, and pr...
Indonesia's e-commerce market to nearly double to $239.4B by 2032, driven by mobile commerce and live shopping trends.
Indonesia's e-commerce market is projected to grow from $120.2 billion in 2027 to $239.4 billion by 2032, with a CAGR of 14.78%. Growth is fueled by rising mobile commerce adoption, live-stream shopping, digital payment solutions like PayLater, and e...
Lawsuit investigation launched over alleged misleading info by NVE Corporation affecting investors.
Rosen Law Firm is investigating potential securities claims against NVE Corporation for allegedly providing misleading business information to investors. Shareholders who purchased NVE securities may be eligible for compensation through a class actio...
Ionis cuts 2026 TRYNGOLZA sales forecast by 50%, shares drop sharply.
Ionis Pharmaceuticals lowered its full-year 2026 sales guidance for its drug TRYNGOLZA from $100-$110 million to about $50 million, citing slower-than-expected market adoption. The drug had generated $32 million in sales in the first half of 2026 but...
QuidelOrtho cuts revenue forecast, announces $100M restructuring; shares drop 14%, investigation launched.
QuidelOrtho reported third-quarter 2026 results with a narrowed full-year revenue outlook and a $100 million restructuring plan extending through 2027. Following the announcement, its shares fell about 14%. The law firm Levi & Korsinsky is investigat...
Zura Bio shares plunge 72% after Phase 2 trial of lead drug tibulizumab fails primary endpoint.
Zura Bio's stock dropped about 72% on November 9, 2026, following the failure of its Phase 2 TibuSHIELD trial for tibulizumab to meet the primary endpoint at Week 16. The trial, involving 247 participants, also missed key secondary endpoints, leading...
Ingredion Q3 EPS misses estimates, shares fall; investigation into potential securities violations launched
Ingredion reported a third-quarter 2026 adjusted EPS that was about 19% lower than the previous year and below Wall Street estimates, causing its shares to drop. Revenue was close to expectations, with only a slight decline in net sales. The earnings...
AAR CORP expands Airbus radome repair services in Asia-Pacific with new multi-year deal
AAR CORP has signed a multi-year agreement with Airbus Avionics to become an authorized repair station for Airbus radomes in the Asia-Pacific region, excluding China. This expands AAR's existing capabilities for Airbus proprietary repairs on aircraft...
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.